Table 6.
The serum lipid profiles in phase I (24 h) and phase II (48 h) for all tested samples (mean ± S.D., n = 4) a.
| Phase I (After 24 h) | Phase II (After 48 h) | |||||||
|---|---|---|---|---|---|---|---|---|
| Group | Total Cholesterol (mg/dL) | Triglycerides (mg/dL) | Total Cholesterol (mg/dL) | Triglycerides (mg/dL) | ||||
| Control | 70.4 | ±9.5 | 131.7 | ±6.7 | 68.9 | ±10.6 | 109.2 | ±4.9 |
| Triton | 256.7 | ±9.0 | 370.1 | ±7.5 | 141.1 | ±6.2 | 221.1 | ±4.5 |
| Unprocessed | 124.7 | ±24.5 (70.8) | 241.4 | ±3.7 (54.0) | 88.7 | ±9.2 (72.6) | 159.8 | ±7.1 (54.8) |
| SS1 | 86.1 | ±8.6 (91.6) | 152.4 | ±2.5 (91.3) | 73.9 | ±4.0 (93.0) | 127.5 | ±3.9 (83.7) |
| SS2 | 89.6 | ±10.8 (89.7) | 173.9 | ±10.5 (82.3) | 74.1 | ±5.9 (92.8) | 139.6 | ±12.2 (72.9) |
| SS3 | 96.7 | ±4.7 (85.9) | 170.8 | ±4.0 (83.6) | 78.3 | ±9.2 (86.9) | 135.4 | ±3.3 (76.6) |
| SD1 | 138.1 | ±1.3 (63.6) | 231.9 | ±5.3 (58.0) | 93.6 | ±9.8 (65.8) | 148.7 | ±5.8 (64.7) |
| SD2 | 146.1 | ±2.3 (59.3) | 243.9 | ±4.1 (52.9) | 91.7 | ±14.0 (68.4) | 165.8 | ±7.6 (49.5) |
| SD3 | 146.3 | ±23.8 (59.2) | 249.7 | ±6.4 (50.5) | 102.9 | ±8.5 (52.9) | 159.8 | ±5.1 (54.8) |
a Data in parentheses represent % inhibition calculate as follows; (1-((serum lipid level of each sample group)-(serum lipid level of control group))/((serum lipid level of Triton group)-(serum lipid level of control)))100.